Press-release for stocks for bristol-myers squibb company

Prices are updated after-hours

Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-03-25 (Crawled : 15:49) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M

| -26.99% | O: 0.11% H: 0.39% C: 0.06%
LLY | News | $726.31 -2.63% -0.04% 3.5M

| 303.12% | O: 0.46% H: 1.46% C: 1.15%
BMY | $48.93 1.3% 0.0% 10M

| -21.46% | O: 1.12% H: 0.0% C: -0.33%
ABBV | $166.41 1.06% 0.0% 5.5M

| 61.47% | O: -0.16% H: 1.21% C: 0.95%
SUPN | $29.43 1.94% 1.9% 360K

| 16.9% | O: -0.32% H: 5.23% C: 4.43%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -4.63% | O: 0.89% H: 0.5% C: 0.41%
OTIC | $0.077

| -97.09% | O: -1.88% H: 2.3% C: 0.0%
OMER | $3.045 -5.14% -5.42% 390K

| -84.32% | O: -1.44% H: 3.5% C: 2.24%
GILD | $66.77 0.92% 0.91% 11M

| 3.75% | O: 0.67% H: 0.15% C: -1.22%
BMRN | $88.68 -1.54% -1.57% 1.8M

| 18.6% | O: -0.72% H: 1.06% C: 0.76%
BCRX | $4.44 -1.33% -1.35% 4.7M

| -57.93% | O: -4.08% H: 7.03% C: 6.04%
AMGN | $269.03 2.39% 2.33% 3.4M

| 9.56% | O: 0.64% H: 0.2% C: -0.32%

| -21.46% | O: 1.12% H: 0.0% C: -0.33%
antibody trial nivolumab

67%

33%

Save your searches and get alerts when important news are released.